UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 原発不明癌の分類およびマネージメントの概要 overview of the classification and management of cancers of unknown primary site
2. 原発不明の腺癌 adenocarcinoma of unknown primary site
3. 骨転移、多発性骨髄腫、およびリンパ腫における完全および切迫病的骨折の評価およびマネージメント evaluation and management of complete and impending pathologic fractures in patients with metastatic bone disease multiple myeloma and lymphoma
4. 原発不明の扁平上皮癌 squamous cell carcinoma of unknown primary site
5. 転移性ホルモン受容体陽性乳癌に対する治療アプローチ：内分泌療法 treatment approach to metastatic hormone receptor positive breast cancer endocrine therapy

English Journal

A comparison of breast cancer tumor cells with varying expression of the Her2/neu receptor by Raman microspectroscopic imaging.

Hartsuiker L1, Zeijen NJ, Terstappen LW, Otto C.
The Analyst.Analyst.2010 Dec;135(12):3220-6. doi: 10.1039/c0an00524j. Epub 2010 Oct 27.
The Her2/neu proto-oncogene is amplified in 25 to 30 percent of human primary breast carcinomas. The roles of Her2/neu have been reported before in literature, showing different relations to intracellular lipid composition. Here, we use Raman microspectroscopic imaging to reveal the chemical composi
PMID 20978707

Construction of a fully retargeted herpes simplex virus 1 recombinant capable of entering cells solely via human epidermal growth factor receptor 2.

Menotti L1, Cerretani A, Hengel H, Campadelli-Fiume G.
Journal of virology.J Virol.2008 Oct;82(20):10153-61. doi: 10.1128/JVI.01133-08. Epub 2008 Aug 6.
A novel frontier in the treatment of tumors that are difficult to treat is oncolytic virotherapy, in which a replication-competent virus selectively infects and destroys tumor cells. Herpes simplex virus (HSV) represents a particularly attractive system. Effective retargeting to tumor-specific recep
PMID 18684832

In vivo delivery of bionanocapsules displaying Phaseolus vulgaris agglutinin-L4 isolectin to malignant tumors overexpressing N-acetylglucosaminyltransferase V.

Kasuya T1, Jung J, Kadoya H, Matsuzaki T, Tatematsu K, Okajima T, Miyoshi E, Tanizawa K, Kuroda S.
Human gene therapy.Hum Gene Ther.2008 Sep;19(9):887-95. doi: 10.1089/hum.2008.037.
Metastasis is a key aspect of tumor malignancy, and several malignant tumors show expression of various mature N-type glycans. In particular, beta1-6 branching N-acetylglucosamine (GlcNAc) is abundantly expressed as a part of high-mannose glycans in various highly metastatic cancers. Phaseolus vulga
PMID 18717644